A5008960935- Acute Myocardial Infarction Research
- Coronary Interventions and Diagnostics
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Imaging and Diagnostics
- Cardiac Arrest and Resuscitation
- Mechanical Circulatory Support Devices
- Infective Endocarditis Diagnosis and Management
- Disaster Response and Management
- Simulation-Based Education in Healthcare
- Cardiac Structural Anomalies and Repair
- Atrial Fibrillation Management and Outcomes
- Heart rate and cardiovascular health
- Cardiac Arrhythmias and Treatments
- Heart Failure Treatment and Management
- Venous Thromboembolism Diagnosis and Management
- Cardiovascular Function and Risk Factors
- Sepsis Diagnosis and Treatment
Yueqing People's Hospital
2025
Liverpool Hospital
2018-2023
Ingham Institute
2020-2023
UNSW Sydney
2022
Concord Repatriation General Hospital
2020-2021
ABSTRACT Background Routine radiofrequency catheter ablation relies on x‐ray imaging, which may increase the risk of radiation exposure to patients. With rapid development intracardiac echocardiography (ICE) technology, it provides a new guidance modality for and shows great potential application in treatment atrial fibrillation (AF). Objective To assess efficacy safety guided AF. Methods A retrospective cohort study was used collect 184 patients who underwent AF from January 2020 September...
Abstract Aims Pharmaco-invasive percutaneous coronary intervention (PI-PCI) is recommended for patients with ST-elevation myocardial infarction (STEMI)who are unable to undergo timely primary PCI (pPCI). The present study examined late outcomes after PI-PCI (successful reperfusion followed by scheduled or failed and rescue PCI)compared pPCI (>120 min from first medical contact). Methods results All STEMI presenting within 12 h of symptom onset, who underwent during their initial...
Objective: To investigate the extent to which multivessel disease, incomplete revascularisation and prescribing differences contribute sex-based outcome disparities in patients with ST-elevation MI (STEMI) establish whether cardiac death (CDMI) rates persist at long-term follow-up. Methods results: This observational study evaluates (median follow-up 3.6 years; IQR [2.4-5.4]) a consecutive cohort of (n=2,083) presenting STEMI undergoing percutaneous coronary intervention). Of studied 20.3%...
Abstract Background Worldwide, and in Australia, a large proportion of patients with ST-segment elevation myocardial infarction (STEMI) are unable to undergo timely primary percutaneous coronary intervention (PCI), so transferred for PCI after receiving fibrinolytic therapy (so-called pharmaco-invasive PCI). Methods Our Hospital, the centre Southwest Sydney, Australia receives both post- rescue or prognostic PCI. Associations were determined between late outcomes (bleeding according Bleeding...
Abstract Introduction There is growing evidence that patients presenting with STEMI in the absence of standard modifiable cardiovascular risk factors (SMuRFs; smoking, hypertension, hypercholesterolemia, diabetes) have poorer outcomes compared to those atleast one SMuRF. It has been hypothesised this may be part due decreased administration pharmacotherapies post-infarct period perceived low risk. Long term without SMuRFs based on reperfusion strategy received during index admission not...